Patel Prashant
Insider
First SEC filing: March 21, 2025 · Latest: March 21, 2025
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 22, 2026 | MEDS | X | 100,000 | · | · | 0 Direct | · | Acquired | (price as of 2026-10-02) |
| June 22, 2026 | MEDS | X | 100,000 | · | · | 282,365 Direct | +54.84% | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | MEDS | A | 5,000,000 | · | · | 5,000,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2026 | MEDS | A | 5,000,000 | $0.20 | $1,000,000 | 9,118,247 Direct | +121.41% | Acquired | -63.2% (price as of 2026-10-02) |
| March 31, 2026 | MEDS | A | 5,000,000 | $0.20 | $1,000,000 | 9,118,247 Direct | +121.41% | Acquired | -63.2% (price as of 2026-10-02) |
| March 31, 2026 | MEDS | A | 5,000,000 | $0.01 | $50,000 | 5,000,000 Direct | · | Acquired | 636.0% (price as of 2026-10-02) |
| March 21, 2025 | MEDS | A | 1,882,247 | · | · | 4,118,247 Direct | +84.18% | Acquired | (price as of 2026-10-02) |
| March 21, 2025 | MEDS | A | 1,500,000 | · | · | 1,500,000 Indirect | · | Acquired | (price as of 2026-10-02) |
| March 21, 2025 | MEDS | A | 700,000 | · | · | 700,000 Indirect | · | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2024 | SCNX | A | 10,000 | · | · | 112,242 Direct | +9.78% | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2024 | SCNX | A | 150,000 | · | · | 150,000 Indirect | · | Acquired | (price as of 2026-10-02) |
| Sept. 1, 2022 | SCNX | A | 8,620 | · | · | 1,261,120 Direct | +0.69% | Acquired | (price as of 2026-10-02) |
| April 19, 2021 | SCNX | S 10b5-1 | 7,500 | $4.39 | $32,925 | 1,252,500 Direct | -0.60% | Disposed | -99.8% (price as of 2026-10-02) |
| Dec. 14, 2020 | SCNX | S 10b5-1 | 7,500 | $5.29 | $39,675 | 1,260,000 Direct | -0.59% | Disposed | -99.8% (price as of 2026-10-02) |
| July 14, 2020 | SCNX | S 10b5-1 | 7,000 | $5.44 | $38,080 | 1,267,500 Direct | -0.55% | Disposed | -99.8% (price as of 2026-10-02) |
| July 13, 2020 | SCNX | S 10b5-1 | 500 | $5.71 | $2,855 | 1,274,500 Direct | -0.04% | Disposed | -99.8% (price as of 2026-10-02) |
| April 14, 2020 | SCNX | A | 50,000 | $6.12 | $306,000 | 1,255,000 Direct | +4.15% | Acquired | -99.8% (price as of 2026-10-02) |
| May 13, 2019 | SCNX | A | 100,000 | · | · | 12,250,000 Direct | +0.82% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 22, 2026 | MEDS | Warrant | Common Stock | $0.00 | March 31, 2031 | 100,000 | Acquired |
| March 31, 2026 | MEDS | Warrant | Common Stock | $0.00 | March 31, 2031 | 5,000,000 | Acquired |
| March 31, 2026 | MEDS | Warrant | Common Stock | $0.01 | March 31, 2031 | 5,000,000 | Acquired |
| May 13, 2019 | SCNX | Stock Option | Common Stock | $0.44 | May 13, 2019 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 21, 2025 | MEDS | Common Stock, par value $0.0001 | 2,236,000 | Direct |
| March 21, 2025 | MEDS | Common Stock, par value $0.0001 | 4,472,000 | Indirect |
| March 21, 2025 | MEDS | Common Stock, par value $0.0001 | 2,400,000 | Indirect |
| Aug. 20, 2014 | SCNX | Common Stock | 7,350,000 | Direct |
| Aug. 20, 2014 | SCNX | Common Stock | 2,500,000 | Indirect |
| Aug. 20, 2014 | SCNX | Common Stock | 2,400,000 | Indirect |